CoChat
Sign Up
Cited by 667

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors

Lange, M., Joly, F., Vardy, J, Ahles, T., Dubois, M., Tron, L., Winocur, G., De Ruiter, M.B., Castel, H.·2019·Annals of Oncology
DOI 10.1093/annonc/mdz410
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/annonc/mdz410

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 126

  1. Joly, 2015, Impact of cancer and its treatments on cognitive function: advances in research from the Paris International Cognition and Cancer Task Force Symposium and update since 2012, J Pain Symptom Manage, 50, 830, 10.1016/j.jpainsymman.2015.06.019 · DOI
  2. Ahles, 2012, Cancer- and cancer treatment-associated cognitive change: an update on the state of the science, J Clin Oncol, 30, 3675, 10.1200/JCO.2012.43.0116 · DOI
  3. Deprez, 2018, International cognition and cancer task force recommendations for neuroimaging methods in the study of cognitive impairment in non-CNS cancer patients, J Natl Cancer Inst, 110, 223, 10.1093/jnci/djx285 · DOI
  4. Wefel, 2011, International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer, Lancet Oncol, 12, 703, 10.1016/S1470-2045(10)70294-1 · DOI
  5. Lange, 2019, Cognitive complaints in cancer survivors and expectations for support: results from a web-based survey, Cancer Med, 8, 2654, 10.1002/cam4.2069 · DOI
  6. Ganz, 2013, Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance, J Natl Cancer Inst, 105, 791, 10.1093/jnci/djt073 · DOI
  7. Joly, 2016, Prospective evaluation of the impact of antiangiogenic treatment on cognitive functions in metastatic renal cancer, Eur Urol Focus, 15, 642, 10.1016/j.euf.2016.04.009 · DOI
  8. Joly, 2019, Potential impact of immunotherapy agents on cognitive function in cancer patients, JNCI
  9. Winocur, 2018, Chemotherapy and cognition: international cognition and cancer task force recommendations for harmonising preclinical research, Cancer Treat Rev, 69, 72, 10.1016/j.ctrv.2018.05.017 · DOI
  10. Amidi, 2017, Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment, Brain Imaging Behav, 11, 769, 10.1007/s11682-016-9552-3 · DOI
  11. Li, 2018, Longitudinal assessment of chemotherapy-induced changes in brain and cognitive functioning: a systematic review, Neurosci Biobehav Rev, 92, 304, 10.1016/j.neubiorev.2018.05.019 · DOI
  12. Ingraham, 1996, An empirical approach to determining criteria for abnormality in test batteries with multiple measures, Neuropsychology, 10, 120, 10.1037/0894-4105.10.1.120 · DOI
  13. Cheung, 2014, Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: cognitive function (FACT-Cog) in breast cancer patients, J Clin Epidemiol, 67, 811, 10.1016/j.jclinepi.2013.12.011 · DOI
  14. Bell, 2018, Important differences and meaningful changes for the Functional Assessment of Cancer Therapy-Cognitive Function (FACTCog), J Patient Rep Outcomes, 2, 1, 10.1186/s41687-018-0071-4 · DOI
  15. Dhillon, 2018, Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy, J Cancer Surviv, 12, 178, 10.1007/s11764-017-0656-6 · DOI · Paper page
  16. Pullens, 2013, Chemotherapy and cognitive complaints in women with breast cancer, Psychooncology, 22, 1783, 10.1002/pon.3214 · DOI
  17. Ng, 2018, Distinct and heterogeneous trajectories of self-perceived cognitive impairment among Asian Breast Cancer Survivors, Psychooncology, 27, 1185, 10.1002/pon.4635 · DOI
  18. Bray, 2018, Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment, J Cancer Surviv, 12, 537, 10.1007/s11764-018-0692-x · DOI
  19. Apple, 2018, Hippocampal functional connectivity is related to self-reported cognitive concerns in breast cancer patients undergoing adjuvant therapy, Neuroimage Clin, 20, 110, 10.1016/j.nicl.2018.07.010 · DOI
  20. Menning, 2017, Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type, PLoS One, 12, e0171724, 10.1371/journal.pone.0171724 · DOI
  21. Lindner, 2014, A meta-analysis of cognitive impairment following adult cancer chemotherapy, Neuropsychology, 28, 726, 10.1037/neu0000064 · DOI
  22. Hodgson, 2013, A meta-analysis of the effects of chemotherapy on cognition in patients with cancer, Cancer Treat Rev, 39, 297, 10.1016/j.ctrv.2012.11.001 · DOI
  23. Collins, 2014, Persistent cognitive changes in breast cancer patients 1 year following completion of chemotherapy, J Int Neuropsychol Soc, 20, 370, 10.1017/S1355617713001215 · DOI
  24. Vardy, 2015, Cognitive function in patients with colorectal cancer who do and do not receive chemotherapy: a prospective, longitudinal, controlled study, J Clin Oncol, 33, 4085, 10.1200/JCO.2015.63.0905 · DOI
  25. Wouters, 2016, Neurocognitive function of lymphoma patients after treatment with chemotherapy, Acta Oncol, 55, 1121, 10.1080/0284186X.2016.1189092 · DOI
  26. Hess, 2015, Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: an NRG oncology/gynecologic oncology group study, Gynecol Oncol, 139, 541, 10.1016/j.ygyno.2015.10.003 · DOI
  27. Ganz, 2014, Cognitive function after the initiation of adjuvant endocrine therapy in early-stage breast cancer: an observational cohort study, J Clin Oncol, 32, 3559, 10.1200/JCO.2014.56.1662 · DOI
  28. Amidi, 2015, Long-term subjective cognitive functioning following adjuvant systemic treatment: 7-9 years follow-up of a nationwide cohort of women treated for primary breast cancer, Br J Cancer, 113, 794, 10.1038/bjc.2015.243 · DOI
  29. Janelsins, 2017, Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls: an analysis from a nationwide, multicenter, prospective longitudinal study, J Clin Oncol, 35, 506, 10.1200/JCO.2016.68.5826 · DOI
  30. Galica, 2012, The impact of chemotherapy-induced cognitive impairment on the psychosocial adjustment of patients with nonmetastatic colorectal cancer, Clin J Oncol Nurs, 16, 163, 10.1188/12.CJON.163-169 · DOI
  31. Pereira, 2015, Neurological complications of breast cancer: a prospective cohort study, Breast, 24, 582, 10.1016/j.breast.2015.05.006 · DOI
  32. Dubois, 2014, Chemotherapy-induced long-term alteration of executive functions and hippocampal cell proliferation: role of glucose as adjuvant, Neuropharmacology, 79, 234, 10.1016/j.neuropharm.2013.11.012 · DOI
  33. Fardell, 2013, The short and long term effects of docetaxel chemotherapy on rodent object recognition and spatial reference memory, Life Sci, 93, 596, 10.1016/j.lfs.2013.05.006 · DOI
  34. Winocur, 2012, The effects of chemotherapy on cognitive function in a mouse model: a prospective study, Clin Cancer Res, 18, 3112, 10.1158/1078-0432.CCR-12-0060 · DOI
  35. Fardell, 2015, The long-term impact of oxaliplatin chemotherapy on rodent cognition and peripheral neuropathy, Behav Brain Res, 291, 80, 10.1016/j.bbr.2015.04.038 · DOI
  36. Fardell, 2014, The impact of sustained and intermittent docetaxel chemotherapy regimens on cognition and neural morphology in healthy mice, Psychopharmacology (Berl), 231, 841, 10.1007/s00213-013-3301-8 · DOI
  37. Seigers, 2016, Neurobiological changes by cytotoxic agents in mice, Behav Brain Res, 299, 19, 10.1016/j.bbr.2015.10.057 · DOI
  38. Lim, 2016, PET evidence of the effect of donepezil on cognitive performance in an animal model of chemobrain, Biomed Res Int, 2016, 1
  39. Christie, 2012, Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy, Clin Cancer Res, 18, 1954, 10.1158/1078-0432.CCR-11-2000 · DOI · Paper page
  40. Lomeli, 2017, Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats, Free Radic Biol Med, 102, 274, 10.1016/j.freeradbiomed.2016.11.046 · DOI
  41. Pomykala, 2013, The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer, Brain Imaging Behav, 7, 511, 10.1007/s11682-013-9243-2 · DOI
  42. Lyon, 2016, Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer, J Neuroimmunol, 301, 74, 10.1016/j.jneuroim.2016.11.002 · DOI
  43. Schilder, 2012, Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study, Psychooncology, 21, 479, 10.1002/pon.1928 · DOI
  44. Danhauer, 2013, Positive and negative affect, depression, and cognitive processes in the Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) Trial, Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, 20, 532, 10.1080/13825585.2012.747671 · DOI
  45. Bender, 2015, Patterns of change in cognitive function with anastrozole therapy, Cancer, 121, 2627, 10.1002/cncr.29393 · DOI
  46. Le Rhun, 2015, A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy, Breast Cancer Res Treat, 152, 569, 10.1007/s10549-015-3493-1 · DOI
  47. Phillips, 2016, Adjuvant ovarian function suppression and cognitive function in women with breast cancer, Br J Cancer, 114, 956, 10.1038/bjc.2016.71 · DOI
  48. Van, 2019, The cognitive effects of endocrine therapy in survivors of breast cancer: a prospective longitudinal study up to 6 years after treatment, Cancer, 125, 681, 10.1002/cncr.31858 · DOI
  49. Wiechno, 2013, Does pharmacological castration as adjuvant therapy for prostate cancer after radiotherapy affect anxiety and depression levels, cognitive functions and quality of life?, Psychooncology, 22, 346, 10.1002/pon.2095 · DOI
  50. Gonzalez, 2015, Course and predictors of cognitive function in patients with prostate cancer receiving androgen-deprivation therapy: a controlled comparison, J Clin Oncol, 33, 2021, 10.1200/JCO.2014.60.1963 · DOI
  51. Morote, 2017, Cognitive function in patients with prostate cancer receiving luteinizing hormone-releasing hormone analogues: a prospective, observational, multicenter study, Int J Radiat Oncol Biol Phys, 98, 590, 10.1016/j.ijrobp.2017.02.219 · DOI
  52. Thiery-Vuillemin, 2018, Impact of abiraterone acetate plus prednisone or enzalutamide on fatigue and cognition in patients with metastatic castration-resistant prostate cancer: initial results from the observational AQUARiUS study, ESMO Open, 3, e000397, 10.1136/esmoopen-2018-000397 · DOI
  53. McGinty, 2014, Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis, Support Care Cancer, 22, 2271, 10.1007/s00520-014-2285-1 · DOI
  54. Dubois, 2014, Evaluation of the impact of the cancer therapy everolimus on the central nervous system in mice, PLoS One, 9, e113533, 10.1371/journal.pone.0113533 · DOI
  55. McGinnis, 2017, Neuroinflammatory and cognitive consequences of combined radiation and immunotherapy in a novel preclinical model, Oncotarget, 8, 9155, 10.18632/oncotarget.13551 · DOI
  56. Ramalho, 2017, Cognitive impairment in the first year after breast cancer diagnosis: a prospective cohort study, Breast, 32, 173, 10.1016/j.breast.2017.01.018 · DOI
  57. Vardy, 2019, A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer, Brain Imaging Behav, 13, 15, 10.1007/s11682-017-9728-5 · DOI
  58. Li, 2015, Perceived cognitive impairment in Chinese patients with breast cancer and its relationship with post-traumatic stress disorder symptoms and fatigue, Psychooncology, 24, 676, 10.1002/pon.3710 · DOI
  59. Cheung, 2012, Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in Asian breast cancer patients, Ann Pharmacother, 46, 1645, 10.1345/aph.1R408 · DOI
  60. Seliktar, 2015, Cognition in breast cancer survivors: hormones versus depression, Psychooncology, 24, 402, 10.1002/pon.3602 · DOI
  61. Libert, 2017, Cognitive compensatory processes of older, clinically fit patients with hematologic malignancies undergoing chemotherapy: a longitudinal cohort study, Psychooncology, 26, 2086, 10.1002/pon.4424 · DOI
  62. Menning, 2016, Cognitive impairment in a subset of breast cancer patients after systemic therapy-results from a longitudinal study, J Pain Symptom Manage, 52, 560, 10.1016/j.jpainsymman.2016.04.012 · DOI
  63. Kesler, 2017, Probability of Alzheimer's disease in breast cancer survivors based on gray-matter structural network efficiency, Alzheimers Dement (Amst), 9, 67, 10.1016/j.dadm.2017.10.002 · DOI
  64. Schagen, 2012, Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients, Psychooncology, 21, 1132, 10.1002/pon.2011 · DOI
  65. Jacobs, 2017, Increased cognitive problem reporting after information about chemotherapy-induced cognitive decline: the moderating role of stigma consciousness, Psychol Health, 32, 78, 10.1080/08870446.2016.1244535 · DOI
  66. Morin, 2018, Treatment with chemotherapy and cognitive functioning in older adult cancer survivors, Arch Phys Med Rehabil, 99, 257, 10.1016/j.apmr.2017.06.016 · DOI
  67. Chen, 2018, Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer, Breast Cancer Res Treat, 172, 363, 10.1007/s10549-018-4911-y · DOI
  68. Rambeau, 2019, Prospective comparison of the Montreal Cognitive Assessment (MoCA) and the Mini Mental State Examination (MMSE) in geriatric oncology, J Geriatr Oncol, 10, 235, 10.1016/j.jgo.2018.08.003 · DOI
  69. Mandelblatt, 2018, Cancer-related cognitive outcomes among older breast cancer survivors in the thinking and living with cancer study, J Clin Oncol, 10.1200/JCO.18.00140 · DOI
  70. Mandelblatt, 2016, Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance), Cancer, 122, 3555, 10.1002/cncr.30208 · DOI
  71. Lange, 2019, Cognitive changes after adjuvant treatment in older adults with early-stage breast cancer, Oncologist, 24, 62, 10.1634/theoncologist.2017-0570 · DOI
  72. Lange, 2016, Decline in cognitive function in older adults with early-stage breast cancer after adjuvant treatment, Oncologist, 21, 1337, 10.1634/theoncologist.2016-0014 · DOI
  73. Anstey, 2015, Self-reported history of chemotherapy and cognitive decline in adults aged 60 and older: the PATH through life project, Gerona, 70, 729, 10.1093/gerona/glt195 · DOI
  74. Okereke, 2019, More evidence of an inverse association between cancer and alzheimer disease, JAMA Netw Open, 2, e196167., 10.1001/jamanetworkopen.2019.6167 · DOI
  75. Cherrier, 2019, Impact of androgen deprivation therapy on mood, cognition, and risk for AD, Urol Oncol
  76. Shaffer, 2012, Chemotherapy was not associated with cognitive decline in older adults with breast and colorectal cancer: findings from a prospective cohort study, Med Care, 50, 849, 10.1097/MLR.0b013e31825a8bb0 · DOI
  77. Carroll, 2019, Cognitive performance in survivors of breast cancer and markers of biological aging, Cancer, 125, 298, 10.1002/cncr.31777 · DOI
  78. Ahles, 2014, Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking, Psychooncology, 23, 1382, 10.1002/pon.3545 · DOI
  79. van der Willik, 2018, Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study, Breast Cancer Res, 20, 135, 10.1186/s13058-018-1062-3 · DOI
  80. Cheung, 2015, Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study, Ann Oncol, 26, 1446, 10.1093/annonc/mdv206 · DOI
  81. Williams, 2018, Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy, J Neuroimmunol, 314, 17, 10.1016/j.jneuroim.2017.10.005 · DOI
  82. Chae, 2016, Impact of TNF-alpha (rs1800629) and IL-6 (rs1800795) polymorphisms on cognitive impairment in Asian breast cancer patients, PLoS One, 11, e0164204, 10.1371/journal.pone.0164204 · DOI
  83. Andreano, 2012, Effects of breast cancer treatment on the hormonal and cognitive consequences of acute stress, Psychooncology, 21, 1091, 10.1002/pon.2006 · DOI
  84. Chae, 2018, Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study, Breast Cancer Res Treat, 168, 713, 10.1007/s10549-017-4640-7 · DOI
  85. Kesler, 2013, Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy, Brain Imaging Behav, 7, 501, 10.1007/s11682-013-9228-1 · DOI
  86. Natori, 2015, Potential role of pNF-H, a biomarker of axonal damage in the central nervous system, as a predictive marker of chemotherapy-induced cognitive impairment, Clin Cancer Res, 21, 1348, 10.1158/1078-0432.CCR-14-2775 · DOI
  87. Merriman, 2014, Association between an interleukin 1 receptor, type I promoter polymorphism and self-reported attentional function in women with breast cancer, Cytokine, 65, 192, 10.1016/j.cyto.2013.11.003 · DOI
  88. Koleck, 2014, Apolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancer, Oncol Nurs Forum, 41, E313, 10.1188/14.ONF.E313-E325 · DOI
  89. Cheng, 2016, The COMT (rs165599) gene polymorphism contributes to chemotherapy-induced cognitive impairment in breast cancer patients, Am J Transl Res, 8, 5087
  90. Ng, 2016, Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer, Neuro Oncol, 18, 244, 10.1093/neuonc/nov162 · DOI
  91. Jenkins, 2016, A feasibility study exploring the role of pre-operative assessment when examining the mechanism of ‘chemo-brain’ in breast cancer patients, Springerplus, 5, 390., 10.1186/s40064-016-2030-y · DOI
  92. Kim, 2017, Altered intrinsic brain activity after chemotherapy in patients with gastric cancer: a preliminary study, Eur Radiol, 27, 2679, 10.1007/s00330-016-4578-x · DOI
  93. Lepage, 2014, A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients, Springerplus, 3, 444, 10.1186/2193-1801-3-444 · DOI
  94. McDonald, 2013, Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study, Brain Behav Immun, 30, S117, 10.1016/j.bbi.2012.05.007 · DOI
  95. Amidi, 2017, Changes in brain structural networks and cognitive functions in testicular cancer patients receiving cisplatin-based chemotherapy, J Natl Cancer Inst, 109, 9041, 10.1093/jnci/djx085 · DOI
  96. Deprez, 2012, Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning, J Clin Oncol, 30, 274, 10.1200/JCO.2011.36.8571 · DOI
  97. Menning, 2018, Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study, Brain Imaging Behav, 12, 324, 10.1007/s11682-017-9695-x · DOI
  98. Chen, 2017, The attention network changes in breast cancer patients receiving neoadjuvant chemotherapy: evidence from an arterial spin labeling perfusion study, Sci Rep, 7, 1
  99. Nudelman, 2014, Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusion, PLoS One, 9, e96713., 10.1371/journal.pone.0096713 · DOI
  100. Conroy, 2013, Chemotherapy-induced amenorrhea: a prospective study of brain activation changes and neurocognitive correlates, Brain Imaging Behav, 7, 491, 10.1007/s11682-013-9240-5 · DOI
  101. Deprez, 2014, Longitudinal assessment of chemotherapy-induced alterations in brain activation during multitasking and its relation with cognitive complaints, J Clin Oncol, 32, 2031, 10.1200/JCO.2013.53.6219 · DOI
  102. López Zunini, 2013, Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: a prospective fMRI study, Brain Imaging Behav, 7, 460, 10.1007/s11682-012-9213-0 · DOI
  103. McDonald, 2012, Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study, J Clin Oncol, 30, 2500, 10.1200/JCO.2011.38.5674 · DOI
  104. Billiet, 2018, Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?, Brain Imaging Behav, 12, 64, 10.1007/s11682-016-9665-8 · DOI · Paper page
  105. Koppelmans, 2012, Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy, Breast Cancer Res Treat, 132, 1099, 10.1007/s10549-011-1888-1 · DOI
  106. Amidi, 2017, Changes in brain structural networks and cognitive functions in testicular cancer patients receiving cisplatin-based chemotherapy, J Natl Cancer Inst, 109, 10.1093/jnci/djx085 · DOI
  107. Stouten-Kemperman, 2015, Lower cognitive performance and white matter changes in testicular cancer survivors 10 years after chemotherapy, Hum Brain Mapp, 36, 4638, 10.1002/hbm.22942 · DOI
  108. Kesler, 2016, Neurotoxic effects of anthracycline- vs nonanthracycline-based chemotherapy on cognition in breast cancer survivors, JAMA Oncol, 2, 185, 10.1001/jamaoncol.2015.4333 · DOI
  109. Stouten-Kemperman, 2015, Neurotoxicity in breast cancer survivors >/=10 years post-treatment is dependent on treatment type, Brain Imaging Behav, 9, 275, 10.1007/s11682-014-9305-0 · DOI
  110. Stouten-Kemperman, 2015, Very late treatment-related alterations in brain function of breast cancer survivors, J Int Neuropsychol Soc, 21, 50, 10.1017/S1355617714001015 · DOI
  111. Jung, 2017, Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysis, Brain Imaging Behav, 11, 86, 10.1007/s11682-016-9507-8 · DOI
  112. Iarkov, 2016, Post-treatment with cotinine improved memory and decreased depressive-like behavior after chemotherapy in rats, Cancer Chemother Pharmacol, 78, 1033, 10.1007/s00280-016-3161-0 · DOI
  113. Lawrence, 2016, A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy, J Cancer Surviv, 10, 176, 10.1007/s11764-015-0463-x · DOI
  114. Lyons, 2012, Fluoxetine counteracts the cognitive and cellular effects of 5-fluorouracil in the rat hippocampus by a mechanism of prevention rather than recovery, PLoS One, 7, e30010., 10.1371/journal.pone.0030010 · DOI
  115. Bedillion, 2019, Cancer treatment effects on cognition and depression: the moderating role of physical activity, Breast, 44, 73, 10.1016/j.breast.2019.01.004 · DOI
  116. King, 2015, Psychological intervention for improving cognitive function in cancer survivors: a literature review and randomized controlled trial, Front Oncol, 5, 72, 10.3389/fonc.2015.00072 · DOI
  117. Janelsins, 2016, YOCAS(c)(R) yoga reduces self-reported memory difficulty in cancer survivors in a nationwide randomized clinical trial: investigating relationships between memory and sleep, Integr Cancer Ther, 15, 263, 10.1177/1534735415617021 · DOI
  118. Winocur, 2014, Physical exercise prevents suppression of hippocampal neurogenesis and reduces cognitive impairment in chemotherapy-treated rats, Psychopharmacology (Berl), 231, 2311, 10.1007/s00213-013-3394-0 · DOI
  119. Ercoli, 2015, Cognitive rehabilitation group intervention for breast cancer survivors: results of a randomized clinical trial, Psychooncology, 24, 1360, 10.1002/pon.3769 · DOI
  120. Von, 2012, Advanced cognitive training for breast cancer survivors: a randomized controlled trial, Breast Cancer Res Treat, 135, 799, 10.1007/s10549-012-2210-6 · DOI
  121. Knobf, 2014, The effect of a community-based exercise intervention on symptoms and quality of life, Cancer Nurs, 37, E43, 10.1097/NCC.0b013e318288d40e · DOI
  122. Schmidt, 2015, Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: a randomized controlled trial, Int J Cancer, 137, 471, 10.1002/ijc.29383 · DOI
  123. Galiano-Castillo, 2017, Effect of an Internet-based telehealth system on functional capacity and cognition in breast cancer survivors: a secondary analysis of a randomized controlled trial, Support Care Cancer, 25, 3551, 10.1007/s00520-017-3782-9 · DOI
  124. Damholdt, 2016, Web-based cognitive training for breast cancer survivors with cognitive complaints-a randomized controlled trial, Psychooncology, 25, 1293, 10.1002/pon.4058 · DOI
  125. Karschnia, 2019, Pharmacologic management of cognitive impairment induced by cancer therapy, Lancet Oncol, 20, e92, 10.1016/S1470-2045(18)30938-0 · DOI
  126. Ahles, 2018, Cognitive effects of cancer and cancer treatments, Annu Rev Clin Psychol, 14, 425, 10.1146/annurev-clinpsy-050817-084903 · DOI

Cited by

Sorted by citations

See all 667

Metadata

Authors
Lange, M., Joly, F., Vardy, J., Ahles, T., Dubois, M., Tron, L., Winocur, G., De Ruiter, M. B., & Castel, H.
Venue
Annals of Oncology
Publisher
Elsevier BV
Published
2019-12
Volume
30
Issue
12
Pages
1925-1940
ISSN
0923-7534
DOI
10.1093/annonc/mdz410
Cited by
667
References
3
Language
en
Licence
Funders
  • The Cancer and Cognition Platform
  • French Ligue contre le Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors. https://app.cochat.ai/papers/10.1093/annonc/mdz410
The paper
Lange, M., Joly, F., Vardy, J., Ahles, T., Dubois, M., Tron, L., Winocur, G., De Ruiter, M. B., & Castel, H. (2019). Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors. Annals of Oncology. https://doi.org/10.1093/annonc/mdz410